Consulting expertise
We are an international team of experienced consultants from established strategy firms and AI specialists with a strong background in life sciences. We have contributed to the clinical development, value maximization and launch of more than 50 drugs, including some of today’s most successful blockbusters. We have seen our strategies pay off over time in immunology, oncology, vaccines, cardiovascular, and metabolic therapies.
We are relentlessly committed to elevating the level of insights and intelligence to develop high-quality market access and pricing deliverables. We go beyond the obvious solutions to maximize value.
We leverage the ElevioSight predictive models to simulate future scenarios. The model simulates competitor launches and strategies as well as policy changes so we can forecast prices, revenues, profits, and patient reach.
We assembled an elite team of renowned local pricing and reimbursement specialists, payers, key opinion leaders, and negotiation specialists. Our approach to collaborating and engaging with our experts is unique. We aim to challenge conventional thinking to go beyond the obvious solutions.
AI and technology
We believe every innovative product deserves a custom-made, boundary-pushing approach, where our “brains” meet AI-powered “brawn” to maximize impact. We harness the unique synergy of our market access strategists and AI engineers to drive efficiency, focusing on high-value activities while delegating low-value tasks to AI. Our advanced market access and pricing tools, seamlessly integrating AI and big data, generate deeper insights on the strategies that will create value in the future.
To help you win in a rapidly evolving environment, we built a unique strategy and market access consulting practice. Our teams of seasoned consultants and AI specialists developed proprietary tools that allow us to delegate low-value tasks to advanced technologies and focus our time on providing higher-quality insights and recommendations.
ElevioSight predicts drug market evolution and informs clinical development, global market access and pricing strategies. Our models help you select and sequence indications, identify target populations, define positioning, and set price levels to profoundly impact commercial success and patient access.
